Teófilo, Eugénio Jr

Top Publications

Top Publications Authored or Co-Authored by "Teófilo, Eugénio Jr"

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  The Lancet, Volume 393, No. 10167, Year 2019, Citations 249
• Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

  The Lancet HIV, Volume 4, No. 12, Year 2017, Citations 100
• Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

  The Lancet HIV, Volume 4, No. 11, Year 2017, Citations 34
• Six-Week Randomized Controlled Trial to Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients

  Antimicrobial Agents and Chemotherapy, Volume 48, No. 1, Year 2004, Citations 11
• A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients

  Clinical Infectious Diseases, Volume 39, No. 4, Year 2004, Citations 10